Boothbay Fund Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,269
| Closed | -$1.14M | – | 1449 |
|
|
2023
Q4 | $1.14M | Buy |
18,269
+12,017
| +192% | +$752K | 0.03% | 574 |
|
|
2023
Q3 | $284K | Buy |
+6,252
| New | +$284K | 0.01% | 1089 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1656 |
|
|
2021
Q4 | – | Sell |
-3,019
| Closed | -$338K | – | 1732 |
|
|
2021
Q3 | $338K | Sell |
3,019
-10,615
| -78% | -$1.19M | 0.01% | 1054 |
|
|
2021
Q2 | $2.21M | Buy |
13,634
+11,864
| +670% | +$1.92M | 0.07% | 290 |
|
|
2021
Q1 | $216K | Buy |
+1,770
| New | +$216K | 0.01% | 1104 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1106 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 949 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 862 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 785 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 769 |
|
|
2019
Q3 | – | Sell |
-22,905
| Closed | -$1.08M | – | 697 |
|
|
2019
Q2 | $1.08M | Buy |
+22,905
| New | +$1.08M | 0.1% | 192 |
|